Pharmaceutical sales and marketing trends Key insights
|
|
|
- Jodie Lyons
- 10 years ago
- Views:
Transcription
1 Pharmaceutical sales and marketing trends 2011 Key insights
2 Contacts Rolf Fricker Partner Munich, Germany Tobias Handschuh Partner London, England National Analysts Worldwide Susan Schwartz McDonald, PhD President & CEO Philadelphia, PA Jill Glathar, PhD Vice President Philadelphia, PA This report was originally published by Booz & Company in
3 The Pharmaceutical Marketing and Sales Survey 2011 reflects the views of more than 150 industry executives Overview The Pharmaceutical Marketing and Sales Survey 2011 was designed to take the industry temperature with respect to current challenges, and to understand how industry leaders plan to overcome those challenges in the next several years and National Analysts Worldwide collaborated to gather and analyze online survey results from more than 150 pharmaceutical executives. Respondents currently influence, or have responsibility for, commercial sales and/or marketing resources within their organization. They are experienced, having held their positions for an average of five years: They are VPs (15%), directors (52%), and managers (20%). Most are responsible for a product portfolio (46%) or a specific brand (33%). Their responsibilities are primarily for in-line products (83%); the rest focus on products in late-stage clinical development (Phases II to III). All survey participants work in either the United States or one of the big five European Union countries, and they represent a diverse range of pharmaceutical companies. 3
4 68% of respondents believe that the current pharmaceutical model is broken and needs significant repair Q: Many people have raised the idea that the current commercial pharmaceutical model is broken and needs significant repair. To what extent do you agree with this assessment? Is the Pharmaceutical Model Broken? Fewer than 10% believe the model is not broken 68% believe the model is broken 44% 22% 24% 3% 6% Strongly Disagree Disagree Neutral Agree Strongly Agree 4
5 Respondents see significant challenges: Growing price pressure, emphasis on cost-effectiveness, and more restrictive market access Q: Looking ahead, please rate how challenging you believe each of the following industry trends will be over the next two years. 76% Upcoming Industry Challenges [Challenges rated significant by >50% of respondents] 70% 69% 60% 53% 50% Growing healthcare system price/ budget pressures Growing need to demonstrate costeffectiveness/ outcomes More restrictive market access Increasing generic competition Decreasing sales-force access to MDs Patient ability to pay Note: Challenges rated significant (4 or 5) by >50% of respondents; 1 2 = Insignificant challenges; 3 = Neutral; 4 5 = Significant challenges 5
6 Many expect sales-force time for their products to decrease Q: Will the total amount of sales-force time that is allocated to your product(s) change over the next two years? Projected Change in Sales-Force Time Allocated to Primary Product Mean Projected Decrease = 31% Decrease 43% Increase 26% Mean Projected Increase = 58% 32% No Change Note: Predictably, products slated for increase in SF time have longer mean patent life remaining 6
7 Many also expect to shift spend from their current focus community MDs toward key accounts, payors, and hospitals/gpos Q: How, if at all, do you believe the percent of sales and marketing expenditures allocated to these targets will change over the next two years? Projected Change in S&M Expenditure Allocation by Marketing Target Current Mean Expenditure Projected Expenditure Trends Community MDs 29% 32% 49% 19% Key Accounts 13% 3% 50% 47% Key Opinion Leaders 11% 12% 58% 30% Other HCPs 10% 10% 60% 30% Hospitals/GPOs 9% 5% 59% 36% Payors 7% 2% 51% 47% Decrease No Change Increase 7
8 Those who believe the model is broken plan to disproportionately reduce spending on physicians and increase spending on nontraditional stakeholders Q: How, if at all, do you believe the percent of sales and marketing expenditures allocated to these targets will change over the next two years? Projected Change in S&M Expenditure Allocation by Marketing Target (Comparison of planned spending between those who are convinced the model is broken and those who are not) Community MDs -28% -35% Projected Decrease 14% Projected Increase 21% Key accounts -4% 38% -2% 52% Key opinion leaders -12% -12% 28% 31% Respondents not convinced model is broken 1) (n=50) Other HCPs Hospitals/GPOs -10% -10% -4% -5% 16% 26% 32% 45% Respondents convinced model is broken 2) (n=106) Payor 0% -3% 28% 56% 1) Population represents those respondents who answered Strongly Disagree, Disagree or Neutral in Q29 2) Population represents those respondents who answered Strongly Agree or Agree in Q29 8
9 More than 50% of respondents expect to rely more on innovative pricing, payor collaboration, pharmacoeconomic studies, and new service models Q: How, if at all, do you anticipate that your reliance on the following marketing activities will change over the next two years? Projected Change in Marketing Focus Pricing Strategies 6% 35% 59% Innovative Pricing 5% 36% 59% Payor Collaborations 6% 38% 56% Pharmacoeconomic Studies 8% 37% 55% New Service Models 6% 43% 51% Direct-to-Consumer Initiatives 9% 43% 48% Patient Adherence 6% 47% 47% Decrease No Change Increase 9
10 However, to date less than half of all respondents have engaged with payors on their products prior to Phase III Q: Still thinking about the product on which you spend most of your time, how far in advance of launch [are/did] you initially [meeting/meet] with payors to discuss unmet needs and evidence required to support reimbursement? Timing of Payor Engagement - % of Respondents by Product Responsibility - 21% 24% 26% 29% Prior to/during Phase II Between Phase II and Phase III During Phase IIIa/b After Phase III Note: Phase I clinical trials focus on determining the safety of the compound for use in humans Phase II clinical trials check for efficacy Phase III clinical trials confirm safety and efficacy in large patient populations. IIIa trials are intended to support registration/regulatory approval. IIIb trials are started prior to approval, but are primarily intended to support publications rather than registration or label changes. 10
11 More than 50% of respondents surveyed plan to respond with increased spending on social media, mobile technologies, and e-detailing Q: How do you project your budget allocation for the following communications vehicles will change, if at all, over the next two years? MD-oriented Social Media Projected Change in Expenditures for Communication Vehicles 34% Mobile Technologies 6% 39% 55% e-detailing MD-oriented Media Channels Search Engine Optimization Product/Disease Websites Patient-oriented Social Media Platforms Video Conference Technologies Patient-oriented Media Channels Patient Advocacy Sites Telereps 8% 8% 7% 5% 9% 8% 9% 4% 6% 12% 40% 42% 46% 43% 45% MD Print/Journal Advertising 39% 42% 19% 46% 55% 57% 58% 58% 52% 51% 49% 48% 47% 45% 41% 37% 30% Decrease No Change Increase Note: Social media, mobile platforms, and e-detailing are all expected to see a boost in spending; even patient-focused social media uncharted territory is slated for investment 11
12 About National Analysts Worldwide Opportunity Assessment Innovation & Transformation Forecasting & Pricing Positioning & Communications Segmentation & Targeting Brand Strategy Customer Experience National Analysts Worldwide is a unique consultancy that integrates sophisticated market research methods with specialized healthcare industry expertise to guide important business decisions for manufacturers of healthcare solutions around the globe. Throughout a full century of business research leadership, including formation of the industry s oldest specialized healthcare practice, the firm has played a pioneering role in the development of many of the tools that remain industry standards. We continue to offer clients not just the fruits of ongoing methodological evolution, but also a shrewd and pragmatic perspective on how and where to apply emerging techniques, including a full suite of advanced quantitative and qualitative research services overseen by people who qualify as genuine industry thought leaders. Project leaders work closely with a team of in-house methodologists who customize our broad repertoire of choice modeling tools and software -- some of them proprietary -- in ways that build opportunity for innovation and fresh thinking into every assignment. Types of engagements and marketing problems include opportunity assessment and forecasting, clinical trials design, pricing, portfolio strategy, segmentation, positioning, communications, and regulatory support. Our NAscence Bio-Innovation Group helps pharmaceutical companies, large and small, spawn innovative products able to flourish in a challenging, high-stakes environment. The firm is also widely known for its integrated Farsight forecasting and ROI models that reflect the interactions of multiple stakeholders and customers. The firm s balanced expertise in methods and marketing, its history of inventive thinking grounded in real world application, and the advantages of global reach with a cordial, boutique style of client service continue to distinguish us as leading candidates for assignments of strategic importance. Healthcare Financial Services Communications Technology Media Energy Residential Design Technology Consumer Products B2B 12
13 is a global team of practical strategists committed to helping you seize essential advantage. We do that by working alongside you to solve your toughest problems and helping you capture your greatest opportunities. These are complex and high-stakes undertakings often game-changing transformations. We bring 100 years of strategy consulting experience and the unrivaled industry and functional capabilities of the PwC network to the task. Whether you re charting your corporate strategy, transforming a function or business unit, or building critical capabilities, we ll help you create the value you re looking for and impact. We are a member of the 157 countries with more than 184,000 people committed to delivering quality in assurance, tax, and advisory services. Tell us out more by visiting us at strategyand.pwc.com. This report was originally published by Booz & Company in PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see structure for further details. Disclaimer: This content is for general information purposes only, and should not be used as a substitute for consultation with professional advisors. 13
A new era for pharmaceuticals New Commercial Models: What s working and what s not
A new era for pharmaceuticals New Commercial Models: What s working and what s not Executive summary The pharmaceutical industry is undergoing a commercial evolution. Traditional sales and marketing tactics
Transform your bank s operations model. A best practices discussion
Transform your bank s operations model A best practices discussion Contacts Boston John Plansky Partner +1-617-521-8801 john.plansky Chicago Ashish Jain Partner +1-312-578-4753 ashish.jain London Gagan
Email List Growth SURVEY SUMMARY REPORT MARKETING PRACTICES AND PERFORMANCE BENCHMARKS
MARKETING PRACTICES AND PERFORMANCE BENCHMARKS Email List Growth SURVEY SUMMARY REPORT Monthly Research Series Conducted in Partnership with Leading Marketing Solution Providers Email List Growth Survey
Customer planning and trade management Benchmarking study
Customer planning and trade management Benchmarking study Contacts Atlanta Penny Boswell Principal +1-312-578-4883 [email protected] Chicago Paul Leinwand Senior Partner +1-312-578-4573
Data-Driven Marketing
Marketing Practices and Performance Benchmarks Data-Driven Marketing Research Summary Report Ascend2 Research Conducted in Partnership with Leading Marketing Solution Providers Data-Driven Marketing Research
Email List Growth from the Small and Medium-sized Business Perspective
Email List Growth from the Small and Medium-sized Business Perspective Ascend2 Research conducted in partnership with Allegra This work is licensed under the Creative Commons Attribution-NonCommercial
The 2014 Global Innovation 1000 Proven paths to innovation success
The 2014 Global Innovation 1000 Proven paths to innovation success For the past 10 years, Strategy& has analyzed R&D investment at the 1,000 biggest-spending public companies in the world, and explored
BEST PRACTICES RESEARCH
2013 Frost & Sullivan 1 We Accelerate Growth Entrepreneurial Company of the Year Award Pharmaceutical Knowledge Process Outsourcing North America, 2013 Frost & Sullivan s Global Research Platform Frost
Marketing Automation Strategy SURVEY SUMMARY REPORT
MARKETING PRACTICES AND PERFORMANCE BENCHMARKS Marketing Automation Strategy SURVEY SUMMARY REPORT Monthly Research Series Conducted in Partnership with Leading Marketing Solution Providers Marketing Automation
Marketing Automation
Marketing Automation Benchmark Summary Report The most challenging obstacles to marketing automation success in the year ahead and how marketers plan to overcome them. Ascend2 Research Conducted in Partnership
Social Media Strategy
Marketing Strategy and Performance Benchmarks Social Media Strategy Research Summary Report Ascend2 Research Conducted in Partnership with Leading Marketing Solution Providers Social Media Strategy Research
Social Media Marketing
Social Media Marketing Research Benchmarks The most challenging obstacles to social media marketing success in the year ahead and how marketers plan to overcome them. Client Connection Research conducted
Cloud computing An information security perspective
Cloud computing An information security perspective Contacts About the authors Chicago Mike Connolly Senior Partner +1-312-578-4580 mike.connolly @strategyand.pwc.com Düsseldorf Jens Niebuhr Partner +49-211-3890-195
Lead Generation Strategy
Marketing Performance Benchmarks Lead Generation Strategy Research Summary Report Ascend2 Research Conducted in Partnership with Leading Marketing Solution Providers Lead Generation Strategy Research Summary
Market Access for Medical Technology & Pharmaceutical Companies An Organizational Priority in Times of Economic Austerity and Reform
Market Access for Medical Technology & Pharmaceutical Companies An Organizational Priority in Times of Economic Austerity and Reform By Joakim Steen Mikkelsen, Managing Healthcare Counselor, Embassy of
The next challenge in B2B information: The shift beyond workflow to business solutions. AMRinternational.
The next challenge in B2B information: The shift beyond workflow to business solutions Authors AMR International: Denzil Rankine Jay Patel Gil Ozir Jonathan Dufton Brett Stassfurth DeSilva+Phillips: Ken
How To Understand And Understand Biosimilars
Welcome to Biosimilars 20/20, presented by the Specialty Pharma Education Center (SPEC) in partnership with the Specialty Pharma Journal (SPJ). Please note that this is a preliminary agenda that is subject
Benchmark Summary Report
SEO Marketing Benchmark Summary Report The most challenging obstacles to Search Engine Optimization success in the year ahead and how marketers plan to overcome them. Ascend2 Research Conducted in Partnership
Medicare star quality management Charting a path to higher ratings
Medicare star quality management Charting a path to higher ratings Contacts About the authors Chicago Mike Connolly Senior Partner +1-312-578-4580 mike.connolly @strategyand.pwc.com Akshay Jindal Principal
Strategic Consulting Services
Services 1 Leadership Team Mark Levonyak President [email protected] Mobile: 214.460.5051 Martin W. Lee, MD EVP, Clinical Trial Services [email protected] Mobile: 952.373.1405 John Eckardt, MD Chief
COLLABORATIVE INVESTING
ORIGINAL RESEARCH SERIES WHITE PAPER COLLABORATIVE INVESTING PHILOSOPHY. CONCEPT. PRACTICE. Perspectives from Principals & Research Team For private distribution only. This report may not be reproduced
Website Marketing Optimization Benchmark Summary Report
Website Marketing Optimization Benchmark Summary Report The most challenging obstacles to website marketing optimization success in the year ahead and how marketers plan to overcome them. Ascend2 Research
Small & Medium-sized Business (SMB) Lead Generation Benchmark Report
Small & Medium-sized Business (SMB) Lead Generation Benchmark Report Ascend2 Research Conducted in Partnership with Allegra. This work is licensed under the Creative Commons Attribution-NonCommercial 3.0
Translating to the language of payers
Translating to the language of payers Actuarial analyses of new drug therapies Gregory Warren, FSA, MAAA Vice President, Pharmacy Actuarial Consulting 303-714-1022 [email protected] 1 Why are actuaries
PHARMACEUTICAL SALES MANAGEMENT
PHARMACEUTICAL SALES MANAGEMENT SHARPENING CUSTOMER-CENTRIC STRATEGIES TO RESTORE ACCESS AND STRENGTHEN RELATIONSHIPS PUBLICATION DATE FEB. 2014 PAGES 195 CHAPTERS 4 THE BOTTOM LINE: New regulations and
Mark Rohlfing. Vice President of Operations Almac Clinical Services Souderton, Pennsylvania
Mark Rohlfing Vice President of Operations Almac Clinical Services Souderton, Pennsylvania Confidential Almac Group 2014 Who We Are Almac is a global drug development services provider. Our mission is
APCO Worldwide in the UK
APCO Worldwide in the UK APCO Worldwide is an independent global communication, stakeholder engagement and business strategy firm. Our award-winning UK operations were founded in 1995 and offer fully integrated
Service provider strategies for mobile advertising: case studies
Research report Service provider strategies for mobile advertising: case studies Alexandra Rehak October 2008 Research from Analysys Mason Fixed Networks and Services Analysys Mason Fixed Networks and
Digital Marketing Strategy
Reaching the Next Level of Marketing Performance Digital Marketing Strategy Research Summary Report Ascend2 Research Conducted in Partnership with Leading Marketing Solution Providers Digital Marketing
Nutraceutical Medical Research, LLC. By: Latesha Richards, Marketing Coordinator
The Value of Conducting Post-Marketing Clinical Research On Marketing Strategy Development Nutraceutical Medical Research, LLC By: Latesha Richards, Marketing Coordinator Those of us who are marketing
Benchmark Report. SEO Marketing: Sponsored By: 2014 Demand Metric Research Corporation in Partnership with Ascend2. All Rights Reserved.
Benchmark Report SEO Marketing: Sponsored By: 2014 Demand Metric Research Corporation in Partnership with Ascend2. All Rights Reserved. TABLE OF CONTENTS 3 Executive Summary 10 SEO Tactic Execution 4 Achieving
DEFINITIVE ADVICE PRACTICAL GUIDANCE POWERFUL ADVOCACY LLP
European Funds Practice DEFINITIVE ADVICE PRACTICAL GUIDANCE POWERFUL ADVOCACY LLP European Funds Practice Dechert s international Financial Services Practice features an industry-leading group of experienced
Healthcare Internal Audit: In a Time of Transition
The 2015 State of the Internal Audit Profession Study Healthcare Internal Audit: In a Time of Transition The healthcare industry in the United States is facing many challenges with the enactment of legislation
Multiple Sclerosis. Current and Future Players. GDHC1009FPR/ Published March 2013
Multiple Sclerosis Current and Future Players GDHC1009FPR/ Published March 2013 Executive Summary Moderate Growth in the Multiple Sclerosis Market is Expected from 2012 2022 GlobalData estimates the 2012
2015 GLOBAL ASSET MANAGEMENT SURVEY
2015 GLOBAL ASSET MANAGEMENT SURVEY It's not what happens to you, but how you react to it that matters." -Epictetus A survey carried out globally by Linedata. INTRODUCTION It's not what happens to you,
content marketing trends
content marketing trends from the small & medium-sized business perspective an Allegra Marketing Resource Allegra Marketing & Print 3639 N. Marshall Way Scottsdale, AZ 85251 480.941.4842 allegraaz.com
Content Marketing in 2014:
Benchmark Report Content Marketing in 2014: Sponsored By: 2014 Demand Metric Research Corporation in Partnership with Ascend2. All Rights Reserved. TABLE OF CONTENTS 3 Executive Summary 10 Content Campaign
Outbound Marketing in the Content Era Delineo June 2013
Outbound Marketing in the Content Era Delineo June 2013 Outbound marketing in the content era! The findings in this report highlight that content marketing is now an important marketing strategy due to
7th Annual Ambulatory PM & EHR Study
7th Annual Ambulatory PM & EHR Study A view into the world of Practice Management and Electronic Health Record adoption After years of diligently working to adopt EHR solutions, ambulatory physician practices,
MEDICAL DEVICE & DIAGNOSTICS
to Guide Strategic Medical Device and Introduction Medical device and diagnostic makers face myriad challenges when developing a new product, including working within resource and financial constraints,
Research Brief. Using the Model. Category One: Strategy
The Sirius Directions in Services Model The Sirius Directions in Services Model groups sales, marketing and product service providers and agencies into five categories: strategy, reputation, demand, sales
Physician partnership to lead healthcare transformation Picking the right model for your market
Physician partnership to lead healthcare transformation Picking the right model for your market Contacts Chicago Cleveland New York San Francisco Gary Ahlquist Senior Partner +1-312-578-4708 gary.ahlquist
Advancing Analytics in Your Organization
Advancing Analytics in Your Organization Sarah Shillington Leidos Health, EVP Annette Savage Leidos Health, Senior Solutions Manager Bryan Fiekers HIMSS Analytics, Director leidoshealth.com Uniting 25
Customer Experience Management
Customer Experience Management Best Practices for Voice of the Customer (VoC) Programmes Jörg Höhner Senior Vice President Global Head of Automotive SPA Future Thinking The Evolution of Customer Satisfaction
I D C M a r k e t S c a p e : W o r l d w i d e F i n a n c i a l S e r v i c e s C o n s u l t i n g 2 0 1 2 V e n d o r A n a l y s i s
Global Headquarters: 5 Speen Street Framingham, MA 01701 USA P.508.872.8200 F.508.935.4015 www.idc.com C O M P E T I T I V E A N A L Y S I S I D C M a r k e t S c a p e : W o r l d w i d e F i n a n c
Inbound Marketing. Research Summary Report. Reaching the Next Level of Marketing Performance
Reaching the Next Level of Marketing Performance Inbound Marketing Research Summary Report Ascend2 Research Conducted in Partnership with Leading Marketing Solution Providers Inbound Marketing Research
Mergers & acquisitions a snapshot Change the way you think about tomorrow s deals
Mergers & acquisitions a snapshot Change the way you think about tomorrow s deals Stay ahead of the accounting and reporting standards for M&A 1 April 23, 2013 What's inside IPR&D accounting the basics...
DIGITAL SMEs: OPPORTUNITIES FOR CSPs PROVIDING SOCIAL, MOBILE, ANALYTICS AND CLOUD SERVICES
RESEARCH STRATEGY REPORT DIGITAL SMEs: OPPORTUNITIES FOR CSPs PROVIDING SOCIAL, MOBILE, ANALYTICS AND CLOUD SERVICES CHRIS NICOLL and SANDRA O BOYLE Analysys Mason Limited 2015 analysysmason.com About
S P E C I A L I S T A N D M A S T E R S T U D I E S
University Ss, Cyril and Methodius Skopje FACULTY OF PHARMACY S P E C I A L I S T A N D M A S T E R S T U D I E S Healthcare management and pharmacoeconomics Skopje, 2007 STUDY PLAN -Specialist Studies-
Integrated Life Cycle Patient Access Solutions that Maximize Brand ROI
Integrated Life Cycle Patient Access Solutions that Maximize Brand ROI August, 2013 Bob Hastings Vice President of Marketing Pharmaceutical brand marketers are facing a paradigm shift in the way they market
Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive pressures through to 2019
Brochure More information from http://www.researchandmarkets.com/reports/1314569/ Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive
REFERENCE CODE GDHC269DFR PUBLICATION DATE JULY 2013 PREMARIN (POSTMENOPAUSAL VAGINAL ATROPHY) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC269DFR PUBLICATION DATE JULY 2013 PREMARIN Executive Summary Premarin (conjugated estrogen cream): Key Metrics in the Seven Major Pharmaceutical Markets 2012 Market Sales US 5EU Japan
The Role of Regional Medical Advisor (RMA)-Field Medical. Dr. Aju Abraham Varghese Pfizer India. Feb 22 nd 2014
The Role of Regional Medical Advisor (RMA)-Field Medical Dr. Aju Abraham Varghese Pfizer India Feb 22 nd 2014 Disclaimer The opinions expressed in this presentation are solely those of the presenter and
Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum
Open Innovation: An Imperative for the Pharmaceutical Industry Berkeley Innovation Forum October 28-29, 2010 Minneapolis, MN Ted Torphy, Ph.D. Vice President & Head External Innovation Research Capabilities
Clinical Communications Programs with Healthcare Professionals and Patients
A Multichannel Approach Clinical Communications Programs with Healthcare Professionals and Patients A Publicis Touchpoint Solutions White Paper Best Practices Series 2011 Publicis Touchpoint Solutions,
Solutions Overview. Relevant Messages. Platform The industry s most scalable, reliable and secure platform
Company Overview Experian CheetahMail is the trusted service provider of email marketing and customer intelligence technologies for top enterprises worldwide. With the industry's largest client services
Enabling the OTT revolution How telecom operators can stake their claim
Enabling the OTT revolution How telecom operators can stake their claim Contacts About the authors Buenos Aires Ariel Fleichman +54-11-4131-0432 ariel.fleichman Düsseldorf Stefan Eikelmann +49-211-3890-110
Amgen GLOBAL CORPORATE COMPLIANCE POLICY
1. Scope Applicable to all Amgen Inc. and subsidiary or affiliated company staff members, consultants, contract workers and temporary staff worldwide ( Covered Persons ). Consultants, contract workers,
Data Driven Marketing
Data Driven Marketing B2B MARKETING AUTOMATION BENCHMARKS FIND. NURTURE. CONVERT. The most challenging obstacles to B2B Marketing Automation success and how marketers will overcome them in the year ahead.
Canaccord Genuity GPS
Canaccord Genuity GPS O p t i m i z e d Po r t f o l i o s Returns include peace of mind. To us there are no foreign markets. N49º18'1" W121º47'7" investment outcome Superhero Mom Harrison Hot Springs,
Mobile proximity payments: scenarios for market development
Research report Mobile proximity payments: scenarios for market development Helen Nierinck and Andrew Parkin-White June 2008 Research from Analysys Mason Fixed Networks and Services Analysys Mason Fixed
Access. Action. Insight. Healthcare Analytics and Marketing Communications Consultative, Analytical, and Promotional Solutions
Cardinal Health Specialty Solutions Healthcare Analytics and Marketing Communications Consultative, Analytical, and Promotional Solutions Access Action Insight In today s increasingly competitive healthcare
Medical Science Liaison (MSL): Understanding, Engaging and Interacting. Gill Logan Regional Medical Affairs Manager Takeda UK
Medical Science Liaison (MSL): Understanding, Engaging and Interacting Gill Logan Regional Medical Affairs Manager Takeda UK Date of upload, October 2011 Disclosures Takeda UK employee Member of the MSLA
Turning Strategic Insight Into Business Impact
Turning Strategic Insight Into Business Impact VMware Accelerate Advisory Services Identify Opportunities and Create Strategies for the Journey to IT as a Service No longer relegated to simply keeping
Remote Collaboration Solutions In the Financial Services Industry
WHITE PAPER Remote Collaboration Solutions In the Financial Services Industry Using Audio/Web Conferencing to Drive Profitable Growth By Debra Chin Senior Vice President Palmer Research May 2011 This Palmer
Web Copywriting and Web News. Get seen first with matm
Web Copywriting and Web News Get seen first with matm Web Copywriting and Web News from matm If you want to attract more online customers and clients and become more successful, it is essential that the
Analysis of The Telemedicine Market in Asia-Pacific. Affordable Telemedicine Services Are Enabling Business Model Evolution
Analysis of The Telemedicine Market in Asia-Pacific Affordable Telemedicine Services Are Enabling Business Model Evolution July 2015 Contents Section Slide Number Executive Summary 4 Perspectives on Telemedicine
12 Questions to ask before beginning your website redesign
12 Questions to ask before beginning your website redesign About the Author Dallas McMillan is the founder and CEO of Influential. He has spent over 10 years mastering marketing, branding and website design
What s the Return on Investment for an MBA for the CT Surgeon
What s the Return on Investment for an MBA for the CT Surgeon Investment Tuition(etc.) Travel Time Classroom, projects, team conference calls, Alternative costs (value of time) Time away from home Lost
IDC MarketScape Excerpt: Worldwide HR BPO 2014 Vendor Assessment
IDC MarketScape IDC MarketScape Excerpt: Worldwide HR BPO 2014 Vendor Assessment Lisa Rowan THIS IDC MARKETSCAPE EXCERPT FEATURES: ADP IDC MARKETSCAPE FIGURE FIGURE 1 IDC MarketScape HR Business Process
RETHINKING DIGITAL SELLING
RETHINKING DIGITAL SELLING BEST PRACTICES FOR MAXIMIZING RESULTS AND ROI Guiding Principles For Rethinking Your Digital Selling Strategy It s been nearly four years since reps started using tablet-based
Global Pharmaceuticals Marketing Channel Reference EDITION
Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry
COLLEGIATE ECHO MARKETING CHALLENGE www.collegiateecho.org OFFICIAL RULES 2015-2016. Challenge by: Facebook Sponsored by: Marketing EDGE
COLLEGIATE ECHO MARKETING CHALLENGE www.collegiateecho.org OFFICIAL RULES 2015-2016 Challenge by: Facebook Sponsored by: Marketing EDGE 1 COLLEGIATE ECHO MARKETING CHALLENGE About Facebook Founded in 2004,
Vice President, Marketing and Customer Experience Wealth Management
Vice President, Marketing and Customer Experience Wealth Management About the Organization: CUNA Mutual Group is the leading financial services provider to credit unions and their members worldwide. For
Cloud Marketing: Faces in the Cloud
Robert Groebel September 25, 2015 Features Cloud Marketing: Faces in the Cloud Share this article: facebook twitter linkedin google Comments Email Print As the need for more informed conversations with
THE ORBITEX DIFFERENCE
ORBITEX CREATES FINANCIAL SOLUTIONS FOR DISCERNING CLIENTS ORBITEX Financial Services Group is a financial services firm providing clients worldwide with a full range of investment opportunities, including
Assessing Your Business Analytics Initiatives
Assessing Your Business Analytics Initiatives Eight Metrics That Matter WHITE PAPER SAS White Paper Table of Contents Introduction.... 1 The Metrics... 1 Business Analytics Benchmark Study.... 3 Overall
Internet Reputation Management Guide. Building a Roadmap for Continued Success
Internet Reputation Management Guide Building a Roadmap for Continued Success About BrandProtect BrandProtect is the leader in multi-channel Internet threat monitoring and risk mitigation. The company
All the details of the PwC s Mini MBA Programme. The value of knowledge PwC s Mini MBA Programme
All the details of the PwC s Mini MBA Programme The value of knowledge PwC s Mini MBA Programme Contents The value of knowledge 3 Mini MBA structure 4 Business breakdown and map 5 Modules Corporate and
